MedTrace Logo

AdaptRehab imVR: Exploring the Feasibility of imVR for Upper Limb Stroke Rehabilitation in Ethiopia

NCT07412899 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-02-17

No results posted yet for this study

Summary

Stroke is a major cause of long-term disability worldwide, particularly in low- and middle-income countries (LMICs). Upper limb impairments following stroke can substantially limit an individual's ability to perform daily activities and engage in community life. Traditional rehabilitation approaches often require high levels of patient engagement and adherence, which can be challenging. Immersive Virtual Reality (imVR) systems offer a promising alternative by enhancing motivation and engagement, thereby supporting upper limb recovery. This study aims to assess the feasibility of the AdaptRehab imVR system in the Ethiopian context, providing valuable insights to guide the design of a future randomized controlled trial.

Conditions

Interventions

DEVICE

Virtual Reality Headset with immersive exercises.

Participants in this arm will receive AdaptRehab imVR therapy for upper limb stroke rehabilitation. Therapy will be delivered over nine sessions across three weeks. Sessions involve interactive, task-oriented exercises in an immersive VR environment, designed to improve upper limb motor function. Participants' usability, user experience, and cybersickness will be assessed as primary outcomes, while FMA, ARAT, and BBT scores will be collected as secondary outcomes.

Sponsors & Collaborators

  • Hasselt University

    collaborator OTHER

  • Jimma University

    lead OTHER

Principal Investigators

  • Bruno BONNECHERE, Rehabilitation Science · Hasselt University

  • Teklu Gemechu Abessa, Special Needs and Inclusive · Jimma University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-08
Primary Completion
2026-03-26
Completion
2026-04-10

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07412899 on ClinicalTrials.gov